Through this exclusive agreement, OncoHelix and Burjeel strive to bring personalized medicine to clinics and hospitals in the UAE. News Release April 13, 2023: Abu Dhabi, United Arab Emirates: OncoHelix with Burjeel Holdings has partnered to set up a cutting-edge […]

March 20, 2023: Oxford Cancer Biomarkers (OCB) and OncoHelix today announce a new partnership to offer OCB’s advanced genetic tests in Canada for screening and detection of people at risk for colorectal cancer. Based on ground-breaking research at the University […]

March 1, 2023: OncoHelix, a Canada-based organization for advanced molecular and immunology diagnostic testing, has announced the launch of AVENIO® 324 Gene CGP Panel in Canada, a somatic tumour tissue panel matched to the FoundationONE CDx test. This is the […]

Calgary, AB; September 15, 2021: Two Canadian innovative genomics diagnostic companies, OncoHelix and Canexia Health, are partnering to help Canadian cancer patients gain access to precision genomic testing via their oncologist. Using a circulating tumour DNA (ctDNA) or “liquid biopsy” […]